Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases.
Siva S, Jones G, Bressel M, Shaw M, Chander S, Chu J, Plumridge N, Byrne K, Kothari G, Hardcastle N, Gaudreault M, Kron T, Wheeler G, MacManus M, Hanna GG, Ball DL, David S.
Siva S, et al. Among authors: byrne k.
Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):862-870. doi: 10.1016/j.ijrobp.2022.05.034. Epub 2022 Jun 22.
Int J Radiat Oncol Biol Phys. 2022.
PMID: 35752407